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Background
The prioritising of patients based upon clinical need is referred to as ¶WULDJLQJ·. Triaging categorises patients into predefined categories dependent on the
severity of their clinical needs1. This helps to identify those at higher risk who should be attended to first. It is important for pharmacists to be able to
identify high-risk patients with the greatest pharmaceutical need to maximise pharmacy skills and reduce the risk of harm to patients2. Despite the use of
¶3KDUPDFLVW Triage 7RROV· in adults which ensure patients at highest clinical risk are prioritised to receive pharmaceutical care, there is little information on
their use in the paediatric setting3-5 .
Aim
To gain consensus from an expert paediatric and neonatal clinical pharmacist panel on criteria to be applied in the design of a triage tool for use in paediatric 
and neonatal settings.
Methods
Results
A study to Develop Criteria for Use Within a Paediatric Triage 
Tool to be used by Pharmacists to Aid Prioritisation of Patients 
by Clinical Care Issues
Tait J1, Thomson K1, Kinnear M1,2, Souter C1,2, Akram G2
1NHS Lothian Pharmacy Service, Edinburgh, 2Strathclyde Institute of Pharmacy and 
Biomedical Sciences, University of Strathclyde, Glasgow
Criteria 
Deemed 
Appropriate
 Patients on high risk medicines should be reviewed daily
 Patients with a daily aseptic need should be reviewed daily
 Patients with unstable, chronic renal failure  or acute, severe/moderate 
kidney injury should be reviewed daily
 Patients with stable, chronic renal failure or acute, mild kidney injury should 
be seen 48 hourly
 Patients should be acute hepatic impairment should be reviewed 24 hourly,  
those with chronic should be review 48 hourly
 Patients receiving renal replacement, ECMO or plasmapheresis should be 
reviewed daily
 Stable patients with no acute issues can be seen at 3 days or re-referral
 Patients whose medicine is being withheld due to administration issues 
should be reviewed daily
Patients receiving continuous infusions should be seen daily
Criteria 
Which 
Require 
Further 
Exploration
Criteria 
Deemed 
Inappropriat
e
 Patients on psychotropic medicines should be review daily
 Patient with a perceived discharge issue should be seen daily
 All paediatric & neonatal patients should be reviewed daily
 Stable patients can be reviewed at 14 days or re-referral
 Patients prescribed unlicensed/off-label medicine should be reviewed daily
 Patients prescribed >5 regular medicines should be review daily
 Patients receiving renal replacement should only be seen daily if they are 
unstable
 Patients with stable or unstable renal failure should be reviewed daily only if 
changes to their medication have occurred
 Patients with acute, moderate and severe kidney injury should be reviewed 
daily only if changes to their medication have occurred
Criteria for inclusion
Survey Response Recommendation for Inclusion in Triage Tool
Mean Value >4 Criteria appropriate to include
MeanValue 3 - 4
Further exploration is required to determine 
appropriateness
Mean Value <2.9
Criteria is not appropriate to include. Mean response 
and comments analysed to confirm if further exploration 
is appropriate.
Conclusion
A triage tool designed to prioritise the delivery of pharmaceutical care in paediatric and neonatal patients would be beneficial. 18 clinical/pharmaceutical 
criteria were identified and agreed upon by a group of experts which categorise patients into one of three groups. These are to: review daily, review 48 
hourly and review 72 hourly.  The triage tool should be piloted for use in clinical practice prior to use across the wider patient group.
¶,IWKH\DUHDQLQSDWLHQWWKH\
should be seen at least twice 
DZHHNHYHQLIVWDEOH·
When dealing with perceived 
GLVFKDUJHLVVXH¶daily review is 
only required at time of 
dischargeµ
¶0DQ\SDHGLDWULFVRU
neonatal medicines 
are unlicensed which 
do not need reviewed 
GDLO\·
Figure 3. Examples of comments left by participants
Figure 1. Methods used throughout study
Figure 2. Agreement of participants in survey rounds one to three
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Each Delphi Round was conducted using a questionnaire collecting responses via a Likert scale from Scottish Neonatal and Paediatric Pharmacy
Group (SNAPP). Surveys were distributed via online survey platform, Qualtrics©. Ten days were given for completion of surveys with 5 days
between each round.
